DOP2019000117A - Nuevos derivados de quinolina - Google Patents

Nuevos derivados de quinolina

Info

Publication number
DOP2019000117A
DOP2019000117A DO2019000117A DO2019000117A DOP2019000117A DO P2019000117 A DOP2019000117 A DO P2019000117A DO 2019000117 A DO2019000117 A DO 2019000117A DO 2019000117 A DO2019000117 A DO 2019000117A DO P2019000117 A DOP2019000117 A DO P2019000117A
Authority
DO
Dominican Republic
Prior art keywords
compounds
preparation
quinolina
new derivatives
pharmaceutical compositions
Prior art date
Application number
DO2019000117A
Other languages
English (en)
Inventor
Griebenow Nils
Hübsch Walter
Köbberling Johannes
Görgens Ulrich
Börngen Kirsten
Schwarz Hans-Georg
Lindner Niels
Ilg Thomas
Kohler Adeline
Welz Claudia
Kulke Daniel
Hink Maike
Böhm Claudia
Zhuang Wei
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of DOP2019000117A publication Critical patent/DOP2019000117A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La invención abarca nuevos compuestos de quinolina de la fórmula general (I): (I), en la cual A, R1, R2, R3, R4, R5, R6 y Q son como se definen en el presente, procedimientos para la elaboración de dichos compuestos, compuestos intermedios útiles para la elaboración de dichos compuestos, composiciones farmacéuticas y combinaciones que comprenden dichos compuestos y el uso de dichos compuestos para la elaboración de composiciones farmacéuticas para el tratamiento, control y/o prevención de enfermedades, en particular de infecciones con helmintos, como un único agente o en combinación con otros principios activos.
DO2019000117A 2016-11-11 2019-05-10 Nuevos derivados de quinolina DOP2019000117A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16198550 2016-11-11

Publications (1)

Publication Number Publication Date
DOP2019000117A true DOP2019000117A (es) 2019-05-31

Family

ID=57321155

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2019000117A DOP2019000117A (es) 2016-11-11 2019-05-10 Nuevos derivados de quinolina

Country Status (27)

Country Link
US (2) US10889573B2 (es)
EP (1) EP3538512B1 (es)
JP (1) JP7165129B2 (es)
KR (1) KR102595730B1 (es)
CN (1) CN109890793B (es)
AU (1) AU2017357503B2 (es)
BR (1) BR112019009529A2 (es)
CA (1) CA3043298A1 (es)
CL (1) CL2019001292A1 (es)
CO (1) CO2019004776A2 (es)
DK (1) DK3538512T3 (es)
DO (1) DOP2019000117A (es)
ES (1) ES2884073T3 (es)
IL (1) IL266407B (es)
MX (1) MX2019005569A (es)
MY (1) MY196327A (es)
NZ (1) NZ752550A (es)
PH (1) PH12019501034A1 (es)
PL (1) PL3538512T3 (es)
PT (1) PT3538512T (es)
SG (1) SG11201903059SA (es)
SI (1) SI3538512T1 (es)
TW (1) TWI821165B (es)
UA (1) UA126119C2 (es)
UY (1) UY37480A (es)
WO (1) WO2018087036A1 (es)
ZA (1) ZA201903708B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7210483B2 (ja) 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
CN111132977B (zh) * 2017-08-04 2024-07-23 礼蓝动物保健有限公司 用于治疗蠕虫感染的喹啉衍生物
MX2020006185A (es) * 2017-12-15 2020-09-03 Bayer Animal Health Gmbh Proceso para la preparacion de derivados de quinolina.
KR20210006401A (ko) 2018-05-09 2021-01-18 바이엘 애니멀 헬스 게엠베하 신규한 퀴놀린 유도체
EP3643711A1 (en) * 2018-10-24 2020-04-29 Bayer Animal Health GmbH New anthelmintic compounds
JP7304952B2 (ja) * 2018-12-18 2023-07-07 エランコ・ティアゲゾンタイト・アーゲー 二環式誘導体
EP3897842A1 (en) * 2018-12-18 2021-10-27 Elanco Tiergesundheit AG Bicyclic derivatives
BR112021018631A2 (pt) 2019-03-19 2021-11-23 Boehringer Ingelheim Animal Health Usa Inc Compostos anti-helmínticos de aza-benzotiofeno e aza-benzofurano
BR112021024726A2 (pt) * 2019-06-07 2022-01-18 Elanco Tiergesundheit Ag Novos derivados bicíclicos
TW202120490A (zh) * 2019-07-30 2021-06-01 德商拜耳動物保健有限公司 新穎異喹啉衍生物
JP2023507173A (ja) * 2019-12-18 2023-02-21 インターベット インターナショナル ベー. フェー. キノリン構造を含む駆虫剤化合物
US20230174492A1 (en) 2020-04-09 2023-06-08 Bayer Animal Health Gmbh Substituted condensed azines as anthelmintic compounds
WO2021242581A1 (en) 2020-05-29 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds
JP2023553269A (ja) 2020-11-18 2023-12-21 エランコ・ティアゲゾンタイト・アーゲー イヌ糸状虫感染症を治療するためのn-(2,3-ジヒドロ-1,4-ベンゾオキサジン-4-イル)-3-イソプロピル-7-(2,3,5-トリフルオロフェニル)ベンゾ-チオフェン-2-カルボキサミド誘導体及び類似化合物
TW202237600A (zh) 2020-12-04 2022-10-01 瑞士商禮藍動物保健股份有限公司 雙環衍生物
EP4259606A1 (en) 2020-12-11 2023-10-18 Intervet International B.V. Anthelmintic compounds comprising a pyridine structure
US20240043446A1 (en) 2020-12-11 2024-02-08 Intervet Inc. Anthelmintic compounds comprising a thienopyridine structure
EP4148052A1 (en) 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
MX2024005264A (es) 2021-11-01 2024-05-14 Boehringer Ingelheim Vetmedica Gmbh Compuestos de pirrolopiridazina como antihelminticos.

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
KR840000768A (ko) * 1982-07-23 1984-02-27 박이은 무연통의 무연탄 난로
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
WO2006043635A1 (ja) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. 3-トリアゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤
EP1868998B1 (en) 2005-04-01 2016-05-25 VFP Therapies New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
JP4871290B2 (ja) 2005-10-06 2012-02-08 日本曹達株式会社 架橋環状アミン化合物および有害生物防除剤
JP2008214323A (ja) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd 皮膚疾患の治療及び/または予防剤
WO2008154442A1 (en) 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
JP5268461B2 (ja) 2008-07-14 2013-08-21 Meiji Seikaファルマ株式会社 Pf1364物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337940B (zh) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101337937B (zh) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
CN102245028B (zh) 2008-12-12 2014-12-31 先正达参股股份有限公司 用作农药的螺杂环n-氧基哌啶
EP2480537A1 (en) * 2009-09-24 2012-08-01 Basf Se Aminoquinazoline compounds for combating invertebrate pests
WO2011085575A1 (zh) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
EP2575468A1 (en) 2010-05-31 2013-04-10 Syngenta Participations AG Method of crop enhancement
EP2631235B1 (en) 2010-08-31 2016-02-10 Meiji Seika Pharma Co., Ltd. Pest control agent
CN101967139B (zh) 2010-09-14 2013-06-05 中化蓝天集团有限公司 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用
EP2675440B1 (en) 2011-02-14 2020-03-25 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
RU2014126367A (ru) * 2011-11-28 2016-01-27 Е.И.Дюпон Де Немур Энд Компани Производные n-(4-хинолинметил)сульфонамидов и их применение в качестве антигельминтных средств
WO2013096151A1 (en) 2011-12-22 2013-06-27 Glaxosmithkline Llc Chemical compounds
TWI566701B (zh) 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
AR089939A1 (es) 2012-02-09 2014-10-01 Glenmark Pharmaceuticals Sa COMPUESTOS BICICLICOS COMO INHIBIDORES DE mPGES-1
ES2626360T3 (es) 2012-03-30 2017-07-24 Basf Se Compuestos de piridinilideno tiocarbonilo N-sustituidos y su uso para combatir plagas de animales
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
MX2014013069A (es) 2012-04-27 2015-07-06 Dow Agrosciences Llc Composiciones plaguicidas y procesos relacionados.
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
BR112015014909A2 (pt) * 2012-12-20 2017-07-11 Bayer Cropscience Ag derivados de sulfureto de arilo e de sulfóxido de arilo como acaricidas e inseticidas
CN103109816B (zh) 2013-01-25 2014-09-10 青岛科技大学 硫代苯甲酰胺类化合物及其应用
CN103232431B (zh) 2013-01-25 2014-11-05 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
EP2999333B1 (en) 2013-05-23 2018-06-13 Syngenta Participations AG Tank-mix formulations
CN103265527B (zh) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
CN103524422B (zh) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
KR20160072154A (ko) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
CN105636440A (zh) 2013-10-17 2016-06-01 美国陶氏益农公司 制备杀虫化合物的方法
AR098475A1 (es) * 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
US9938292B2 (en) * 2014-03-24 2018-04-10 Guangdong Zhongsheng Pharmaceutical Co., Ltd Quinoline derivatives as SMO inhibitors
WO2016005276A1 (en) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Process for preparing fluorinated iminopyridine compounds
BR112017016996B1 (pt) 2015-02-17 2022-05-31 Nippon Soda Co., Ltd Composição agroquímica
AU2016370779B2 (en) 2015-12-17 2019-07-25 Astex Therapeutics Limited Quinoline-3-carboxamides as H-PGDS inhibitors

Also Published As

Publication number Publication date
EP3538512A1 (en) 2019-09-18
RU2019117917A3 (es) 2021-03-05
US20200024264A1 (en) 2020-01-23
JP7165129B2 (ja) 2022-11-02
EP3538512B1 (en) 2021-06-16
DK3538512T3 (da) 2021-07-05
WO2018087036A1 (en) 2018-05-17
KR20190076980A (ko) 2019-07-02
CA3043298A1 (en) 2018-05-17
SI3538512T1 (sl) 2021-09-30
JP2019535706A (ja) 2019-12-12
UY37480A (es) 2018-06-29
SG11201903059SA (en) 2019-05-30
CN109890793A (zh) 2019-06-14
ZA201903708B (en) 2022-11-30
ES2884073T3 (es) 2021-12-10
MY196327A (en) 2023-03-24
AU2017357503A1 (en) 2019-05-02
NZ752550A (en) 2023-03-31
US10889573B2 (en) 2021-01-12
IL266407A (en) 2019-06-30
PL3538512T3 (pl) 2021-11-22
TWI821165B (zh) 2023-11-11
MX2019005569A (es) 2019-09-05
PH12019501034A1 (en) 2019-12-02
IL266407B (en) 2021-10-31
CO2019004776A2 (es) 2019-07-31
RU2019117917A (ru) 2020-12-11
US20210115026A1 (en) 2021-04-22
CL2019001292A1 (es) 2019-09-27
TW201829384A (zh) 2018-08-16
KR102595730B1 (ko) 2023-10-27
PT3538512T (pt) 2021-08-16
CN109890793B (zh) 2022-11-18
US11505545B2 (en) 2022-11-22
BR112019009529A2 (pt) 2019-07-30
AU2017357503B2 (en) 2022-02-17
UA126119C2 (uk) 2022-08-17

Similar Documents

Publication Publication Date Title
DOP2019000117A (es) Nuevos derivados de quinolina
DOP2020000023A (es) Nuevos derivados de quinolina
UY37789A (es) Nuevos derivados de azaquinolina
ECSP19030002A (es) 1,2,4-triazolonas 2,4,5-trisustituidas
CO2018010966A2 (es) Nuevos derivados de pirazolopirimidina
UY37460A (es) 1,2,4-triazolonas con anelación en 4 y 5
CL2020002891A1 (es) Nuevos derivados de quinolina
UY37705A (es) Nuevos derivados de pirazol bicíclicos
UY37832A (es) Dihidrooxadiazinonas
UY37971A (es) Derivados de indol macrocíclicos sustituidos
UY37250A (es) Derivados macrocíclicos de indol
UY37972A (es) Derivados de indol macrocíclicos sustituidos con cloro
UY37973A (es) Derivados de indol macrocíclicos
UY38816A (es) Nuevos derivados de isoquinolina
ECSP20023626A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
UY37032A (es) Compuestos de heteroarilbenzimidazol